1947–1953: Project CHATTER
1947–1953: U.S. Navy Project CHATTER focused on identifying and testing drugs for interrogations and recruitment of intelligence agents. CIA Mind Control
1947–1953: U.S. Navy Project CHATTER focused on identifying and testing drugs for interrogations and recruitment of intelligence agents. CIA Mind Control
Holocaust survivors, children and grandchildren of survivors express their concerns about the ominous current events. These survivors are likely to be the last generation of witnesses who remember. A Five-Part Docuseries Click here to watch the series To watch the full series, go here now: NeverAgainisNowGlobal.com
Chester M. Southam, MD, a noted immunologist at Sloan-Kettering Institute sought to study the human immunity response to cancer. He obtained funding from the government and injected live cancer cells into 14 patients with advanced cancer and into healthy convicts at Ohio State Prison. The study in prisoners was designed…
1932–1972: Tuskegee Syphilis experiment, “the longest nontherapeutic experiment on human beings in the history of medicine,” continued unabated 25 years after Nuremberg. Tuskegee Syphilis experiment, “the longest nontherapeutic experiment on human beings in the history of medicine” sponsored by the U.S. Public Health Service continued unabated until 1972 — 25…
1958–1962: An Atomic Energy Commission field study — “Project Chariot” — spread radioactive materials over Inupiat land in Point Hope, Alaska. Today, cancer is the leading cause of death in Point Hope. Alaska Dispatch, 2012.
Chemically Induced Psychosis Experiments: An Inhumane Paradigm in Psychiatric Research Congressional Testimony submitted by Vera Sharav * February 2, 2000 Statement For the Record Submitted To U.S. Senate Sub-Committee: Public Health & Safety of the Senate Health, Education, Labor & Pensions Committee Hearing Our efforts helped bring to public attention…
Dr. Chester Southam injected live cancer cells into 22 elderly patients at Jewish Chronic Disease Hospital in Brooklyn. After being rebuffed by his institution, Sloan-Kettering, he convinced Dr. Emanuel Mandel at Jewish Chronic Disease. He sought to learn whether people who were debilitated by cancer could reject cancer cells. None…